Cucurbit[7]uril encapsulated cisplatin overcomes cisplatin resistance via a pharmacokinetic effect.
about
Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]urilThe ex vivo neurotoxic, myotoxic and cardiotoxic activity of cucurbituril-based macrocyclic drug delivery vehicles.Cucurbit [7] uril encapsulated cisplatin overcomes resistance to cisplatin induced by Rab25 overexpression in an intraperitoneal ovarian cancer modelAcyclic Cucurbit[n]uril-Type Molecular Container Enables Systemic Delivery of Effective Doses of Albendazole for Treatment of SK-OV-3 Xenograft TumorsTuning the metabolism of the anticancer drug cisplatin with chemoprotective agents to improve its safety and efficacy.Targeting and delivery of platinum-based anticancer drugs.Host-guest supramolecular nanosystems for cancer diagnostics and therapeutics.Synthetic and bioinspired cage nanoparticles for drug delivery.Probing the pharmacokinetics of cucurbit[7, 8 and 10]uril: and a dinuclear ruthenium antimicrobial complex encapsulated in cucurbit[10]uril.Cucurbit[7]uril: an emerging candidate for pharmaceutical excipients.N-acetyl-L-cysteine modulates the metabolism of cis-platin in human plasma in vitro.Chemoprotection by D-methionine against cisplatin-induced side-effects: insight from in vitro studies using human plasma.Supramolecular chemotherapy based on host-guest molecular recognition: a novel strategy in the battle against cancer with a bright future.Enhancing the solubility and bioactivity of anticancer drug tamoxifen by water-soluble pillar[6]arene-based host-guest complexation.Encapsulation of Mitoxantrone within Cucurbit[8]uril Decreases Toxicity and Enhances Survival in a Mouse Model of Cancer.Concealing the taste of the Guinness World's most bitter substance by using a synthetic nanocontainer.A systematic evaluation of the biocompatibility of cucurbit[7]uril in mice.Applications of Cucurbit[n ]urils (n =7 or 8) in Pharmaceutical Sciences and Complexation of Biomolecules
P2860
Q28538718-4F703608-9A14-4EA9-B544-2BAA2AC8FB47Q34523282-D4080B73-03A3-464E-B7F5-38C3AB4BB2E9Q36073949-E57C0EEB-05B8-455A-B2D2-53A312AC8058Q36665183-D149DEBF-A89F-4448-9EB4-8C02378B1E22Q37441359-5EABB0AD-64C4-4B96-ADD8-DC75AE2DA84CQ38050063-718E75F9-C935-4D32-B1A7-FABCB7B3C52FQ38139328-9C7199A5-0156-42B8-ABAE-D0D6B7C970D0Q38254088-4FAF98CB-A4BB-43D2-A579-11AB81DEC0E9Q38690784-EFDC7503-F01A-483E-B91C-E5AF4940C442Q39425832-62DDD399-2DE8-453E-8960-083C38C19284Q45241480-0796904C-83C5-4358-852F-8D0262FD84ACQ46959686-33E1EE50-2705-4022-801F-315B71B19BE4Q47599299-EC23F212-5270-498F-8FC6-008C7E8AB20CQ47790122-A1FD8701-B337-40F5-90B9-EE4FC4E32C84Q47839279-A93E7FDB-BE2B-49F5-9B6A-951958EE9606Q50524934-30D516B2-AE94-4037-868D-AAC75338CE87Q55235308-AA84CC05-E12A-4DD6-974F-282AD8AD0370Q57617975-DD75E61B-6466-466F-8098-49589FD9C9AA
P2860
Cucurbit[7]uril encapsulated cisplatin overcomes cisplatin resistance via a pharmacokinetic effect.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cucurbit[7]uril encapsulated c ...... via a pharmacokinetic effect.
@en
Cucurbit[7]uril encapsulated c ...... via a pharmacokinetic effect.
@nl
type
label
Cucurbit[7]uril encapsulated c ...... via a pharmacokinetic effect.
@en
Cucurbit[7]uril encapsulated c ...... via a pharmacokinetic effect.
@nl
prefLabel
Cucurbit[7]uril encapsulated c ...... via a pharmacokinetic effect.
@en
Cucurbit[7]uril encapsulated c ...... via a pharmacokinetic effect.
@nl
P2093
P2860
P356
P1433
P1476
Cucurbit[7]uril encapsulated c ...... e via a pharmacokinetic effect
@en
P2093
Balaji Venugopal
Jane A Plumb
Natarajan Sathiyamoorthy Venkataramanan
Natividad Gomez-Roman
Rabbab Oun
Yoshiyuki Kawazoe
P2860
P304
P356
10.1039/C2MT20054F
P577
2012-05-21T00:00:00Z